✦ LIBER ✦
702 Efficacy and Safety of Delayed-Release Oral mesalamine At 4.8g/D (800mg Tablet) in the Treatment of Moderately Active Ulcerative Colitis: Results of the Ascend III Study
✍ Scribed by William J. Sandborn; Jaroslaw Regula; Brian Feagan; Elena A. Belousova; Njegica V. Jojic; Milan -. Lukas; Bruce R. Yacyshyn; Piotr Krzeski; Chyon-Hwa Yeh; Stephen B. Hanauer
- Book ID
- 119428339
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 94 KB
- Volume
- 134
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.